Clark Gavin Rc, Anderson Annie S, Godfrey Thomas G, Strachan Judith A, Fraser Callum G, Steele Robert Jc
Information Services Division, NHS Scotland National Services Division, Edinburgh, Scotland, UK.
Centre for Public Health Nutrition Research, University of Dundee, Dundee, UK.
BMJ Open. 2020 Sep 22;10(9):e037925. doi: 10.1136/bmjopen-2020-037925.
In developed countries, the incidence of colorectal cancer (CRC) has declined in the over 50 years age group but increased in younger people. We studied CRC incidence by age and the influence of screening uptake.
Age-standardised and sex-standardised incidences for CRC from 1997 to 2017 were obtained from the Scottish Cancer Registry (SCR). In addition, linkage between the Scottish Bowel Screening Database and the SCR allowed investigation of any association between screening participation and CRC incidence.
Scotland and the Scottish Bowel Screening Programme, in which guaiac faecal occult blood test screening was piloted from March 2000 and fully rolled by December 2009.
From the introduction of screening in 2000 through to 2017, 2 395 172 were invited to participate, of whom 1 487 999 participated at least once.
Incidence of CRC.
In the screening age range (50-74 years), CRC incidence peaked at 156.5 cases per 100 000 in 2010 after full roll-out of screening across Scotland but fell to 123.9 per 100 000 in 2017. However, under 50 years, there was a rise from 5.3 cases per 100 000 in 2000 to 6.8 per 100 000 in 2017. When CRC incidence was examined in those who had been offered screening, incidence fell in the participant group more than in the non-participant group after roll-out of screening was complete. Analysis of cumulative incidence demonstrated that CRC incidence in the participant group remained consistently below that of the non-participant from around 7 years of follow-up.
The incidence of CRC in Scotland has declined in the over 50 years age group but increased in younger people. It is likely that population screening has contributed to the reduction in CRC incidence in the over 50 years age group.
在发达国家,50岁以上人群的结直肠癌(CRC)发病率有所下降,但在年轻人中却有所上升。我们研究了按年龄划分的CRC发病率以及筛查参与率的影响。
1997年至2017年CRC的年龄标准化和性别标准化发病率来自苏格兰癌症登记处(SCR)。此外,苏格兰肠道筛查数据库与SCR之间的关联使得能够调查筛查参与与CRC发病率之间的任何关联。
苏格兰和苏格兰肠道筛查计划,其中愈创木脂粪便潜血试验筛查于2000年3月进行试点,并于2009年12月全面推广。
从2000年引入筛查到2017年,共有2395172人被邀请参与,其中1487999人至少参与过一次。
CRC发病率。
在筛查年龄范围(50 - 74岁)内,在苏格兰全面推行筛查后,CRC发病率于2010年达到峰值,为每10万人156.5例,但在2017年降至每10万人123.9例。然而,在50岁以下人群中,发病率从2000年的每10万人5.3例上升至2017年的每10万人6.8例。当对接受过筛查的人群的CRC发病率进行检查时,在筛查全面推行完成后,参与者组的发病率下降幅度大于非参与者组。累积发病率分析表明,从大约7年的随访期开始,参与者组的CRC发病率一直低于非参与者组。
苏格兰50岁以上人群的CRC发病率有所下降,但年轻人中的发病率有所上升。很可能人群筛查促成了50岁以上人群CRC发病率的降低。